Symbiotics is pleased to announce the appointment of Christèle Hiss Holliger to its holding Symbiotics Group SA Board of Directors. She joins Jacques de Saussure, as Chairman, Beth Krasna, David Ledermann and Antoine Delaporte.
Symbiotics is similarly pleased to announce her appointment to the affiliated Symbiotics Asset Management SA board of directors, together with Sandrine Massiani. They join in this role Piercarlo Gera, as well as Roland Dominicé, Chief Executive of the holding company, and Amy Bergstraesser, Head of Legal.
Christèle Hiss Holliger brings a wealth of experience from a 30-year career in banking and institutional asset management, with senior executive roles in sales and people management. She started her career at BNP Paribas, where she worked as an Institutional Sales Manager in Paris and as Investment Strategist in Geneva. Later, she joined Pictet Asset Management and became Head of Institutional Clients in Geneva, then CEO of its Singapore operations, covering Southeast Asian institutional clients. She was then appointed Global Head of HR for Pictet Group, and a member of the Group Executive Committee. Christèle recently retired from her executive career and joined the boards of L’Occitane International Group and the Pictet Group Foundation.
Sandrine Massiani brings a wealth of experience from a 28-year career in microfinance, SME banking and development finance with senior executive positions in risk management and staff development. She started her career at BNP Paribas as Financial Controller and then Head of Management Reporting in Frankfurt and Singapore. Later, she joined IPC, the leading German development consulting group, and eventually joined Procredit Holding in Frankfurt, the SME banking group they created, as Regional Coordinator for Africa. She was later appointed as HR coordinator for the entire group, and then as Group Head of Audit, HR, IT and Risk. She eventually joined the Group Executive Management Board, where she spent 8 years.
“We are extremely pleased to see Christèle Hiss Holliger and Sandrine Massiani join us. They are very talented professionals bringing relevant and complementary expertise for our asset management and development finance practice.”, said Roland Dominicé, who will chair the Symbiotics Asset Management board.
He added: “These governance changes are part of the completion of our overall transformation strategy 2025, which put the group, and our four business lines: Investments, Asset Management, Fund Solutions and Capacity Building, in the best of conditions to grasp new opportunities offered by sustainable finance today. Having just passed USD 10 billion in investments for our 20th anniversary, we hope to replicate and grow this track record in the coming decades.”
*******
About Symbiotics Group
Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 7,900 investments representing more than USD 10 billion for 598 companies in 97 countries. We manage an aggregate portfolio of USD 2.8 billion spread across 20 funds and mandates. Our portfolio companies have also benefited from over 170 technical assistance projects worth more than USD 19 million. symbioticsgroup.com
*******
For more information contact:
Roberta Maurutto, Corporate Communication Specialist
roberta.maurutto@symbioticsgroup.com
